AKT1 and hydrops fetalis: OPC-rich extracts of hawthorn (Crataegus oxyacantha) have long been employed in the clinical management of HF, and their high-molecular weight OPCs have likewise been found to activate eNOS in vitro via PI3K/Akt [307,308].